ALLIANCEBERNSTEIN L.P. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$39,393
+21.1%
315,9000.0%0.00%
Q4 2022$32,538
+20.5%
315,900
+76.8%
0.00%
Q3 2022$27,000
-6.9%
178,700
+439.9%
0.00%
Q2 2022$29,000
+7.4%
33,100
+53.2%
0.00%
Q1 2022$27,000
-64.9%
21,600
-45.5%
0.00%
Q4 2021$77,000
-29.4%
39,6000.0%0.00%
Q3 2021$109,000
-12.8%
39,6000.0%0.00%
Q2 2021$125,00039,6000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 20,000$14,0000.02%
Hartford Financial Management Inc. 16,000$11,0000.00%
RBF Capital, LLC 25,000$19,0000.00%
Koshinski Asset Management, Inc. 20,000$14,0000.00%
Financial Advocates Investment Management 23,097$16,0000.00%
D.A. DAVIDSON & CO. 110,000$76,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 162,714$112,0000.00%
HighTower Advisors, LLC 132,328$91,0000.00%
Virtu Financial LLC 15,854$11,0000.00%
BlackRock Inc. 31,631$22,0000.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders